Privium Fund Management UK Ltd Takes $2.06 Million Position in Synopsys, Inc. $SNPS

Privium Fund Management UK Ltd acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,600 shares of the semiconductor company’s stock, valued at approximately $2,057,000. Synopsys accounts for 0.9% of Privium Fund Management UK Ltd’s holdings, making the stock its 21st biggest holding.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Financial Management Professionals Inc. increased its holdings in shares of Synopsys by 7.0% in the fourth quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after acquiring an additional 22 shares in the last quarter. Foronjy Financial LLC lifted its holdings in shares of Synopsys by 5.2% during the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after purchasing an additional 22 shares in the last quarter. AGH Wealth Advisors LLC grew its position in shares of Synopsys by 4.4% in the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after purchasing an additional 24 shares during the period. Hardy Reed LLC grew its position in shares of Synopsys by 0.8% in the 4th quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company’s stock valued at $1,554,000 after purchasing an additional 25 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC increased its stake in Synopsys by 16.9% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company’s stock worth $85,000 after purchasing an additional 26 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: A discounted-cash-flow analysis suggests Synopsys may be undervalued by approximately 26%, offering potential upside if the company converts strong AI and semiconductor-design demand into sustained cash-flow growth. Synopsys Stock May Be Cheap As Shares Fell 33%
• Positive Sentiment: Analysts and market commentators point to 42% revenue growth, raised guidance and Synopsys’ completed $35 billion acquisition as catalysts that could eventually support a recovery toward substantially higher price levels. These forecasts are speculative and depend on successful integration and continued AI-silicon spending. Prediction: Synopsys Will Hit $650 on This Date

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Synopsys Stock Performance

SNPS stock opened at $421.50 on Monday. The stock has a market cap of $80.71 billion, a price-to-earnings ratio of 97.57, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. The company has a fifty day moving average price of $425.63 and a two-hundred day moving average price of $442.93. Synopsys, Inc. has a one year low of $366.00 and a one year high of $626.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business’s revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on SNPS shares. BNP Paribas Exane lifted their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a research note on Wednesday, May 27th. Bank of America boosted their price target on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Stifel Nicolaus upped their price objective on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $565.06.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.